1. Introduction {#sec0001}
===============

The continuing novel coronavirus or SARS-CoV-2 epidemic has been declared a pandemic by the World Health Organization (WHO) on March 11, 2020 [@bib0001]. According to Worldometer data 3,401,394 total confirmed cases, 239,615 confirmed deaths and 1,083,816 recovered throughout the world as of May 02, 2020 [@bib0002]. Novel coronavirus has already exceeded the earlier records of two life-threatening outbreaks, namely Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV), posing the major warning to the global public health and economy after the 2nd world war [@bib0003]. COVID-19 are a group of enveloped non-segmented with a positive-sense, single-stranded RNA viruses that belongs to the order of Nidovirales, family of Coronaviridae, and subfamily of Orthocoronavirinae and widely spread among the mammals and humans [@bib0004]. The novel coronavirus disease is an infectious disease caused by SARS-CoV-2.

A local epidemic of pneumonia was first identified in December 2019 in Wuhan city of Hubei province China, and the mainland China became the epicenter of COVID-19 [@bib0005]. Most of the initial stages were usually incorporated to the wholesale Huanan seafood market, which also traded live animals. This communicable coronavirus disease has traits like fever, dry cough, sore throat, breathlessness and fatigue [@bib0006]. With human migration through air, the disease has now spread throughout the world as well as the territories of the world, making Europe and USA as new epicenters [@bib0007]. It is the third zoonotic human-to-human transmission COVID-19 that has arisen in the present century, after SARS-CoV, which spread around 37 countries and the MERS-CoV, which spread around 27 countries.

In India, the pandemic COVID-19 was first confirmed in the state Kerala on January 30, 2020 when a student returned back from Wuhan, the province of China [@bib0008]. The Govt. of India has incorporated social distancing as a precautionary measure to prevent the possibility of a stage-3 human-to-human transmission that can stimulate the spread of the coronavirus diseases. India Govt. also imposed a 14 hours voluntary public curfew ('Janata Curfiew') on March 22, 2020 to make aware the people about the peculiar epidemiological traits compared with previous two epidemics of SERS-CoV and MERS-CoV. Moreover, the Govt. of India has declared a 21 days nationwide lockdown from March 25, 2020 to April 14, 2020 to prevent the spread of coronavirus diseases among human, affecting India's 1.3 billion population. In the second phase, the lockdown has been extended up to May 03, 2020 to combat against COVID-19 pandemic in India. In lack of any specific vaccine or therapeutics, social distancing has been recognized as the most commonly utilized preventive measures to control the novel coronavirus diseases [@bib0009]. The main aim of these initiatives are the control of social interactive places, like schools, colleges, theaters, cultural programme and other public spheres, except for essential public services like hospitals, medicine shops, police and fire etc. Indeed the outbreaks of COVID-19 has drastically altered the daily life, health of the publics as well the economy. This is one of the main interests for each and everyone how long this situation will continue and when the disease will be under controlled and the entire world will be returned back to its earlier situation.

As identified by the World Health Organization (WHO), the mathematical models, mainly those formulated in a timely manner, can play a crucial role in allowing public health decision and policy-makers with evidence-based statistics [@bib0010], [@bib0011]. Mathematical modeling can aid in understanding; (i) how transmissible the disease is, (ii) when does the infectivity become high during the course of epidemic, (iii) how acute the disease is, and (iv) how effectual interventions has been and ought to be. It is not surprising that the researchers throughout the world have been trying to successfully model the coronavirus diseases. The group of modelers throughout the global has accepted the challenge in delineating mathematical models of the transmission dynamics of COVID-19 or SARS-CoV-2 and has rapidly reacted to the ongoing novel coronavirus epidemic. The progression of any outbreak depends on the infectivity of pathogens as well as the available uninfected individuals.

For a novel infection, when the transmission dynamics of an epidemiological disease is unknown, mathematical models play a key role to estimates the number of worst and best case scenarios. It can also aid in estimating the effect of precautionary measures adopted against novel coronavirus. With preventive techniques, the main object is to preserve the basic reproduction number *R* ~0~ below 1, to control further development of infection, whereas in a mitigation policy, the main object is to indelicate the effect of outbreak [@bib0009]. Recently, some mathematical models have already been investigated to understand the transmission dynamics of peculiar epidemiological traits of COVID-19, and some of these are listed in our references [@bib0012], [@bib0013], [@bib0014], [@bib0015], [@bib0016], [@bib0017], [@bib0018], [@bib0019], [@bib0020], [@bib0021]. Modeling the dynamics of COVID-19 pandemic is not new and most of the authors focused on the effect of lockdown due to absence of any effective therapeutics or licensed vaccine. In this context A. Atangana [@bib0012] studied a mathematical model to study the transmission dynamics of COVID-19 pandemic by using a system of fractional differential equations by using the effect of lockdown. Tang and colleagues [@bib0013] proposed a model for COVID-19 by considering symptomatic individuals to get the patients' epidemiological status and calculated the basic reproduction number 6.47, which is very high for the infectious diseases. Giordano and colleagues [@bib0015] developed a new SIDARTHE model for COVID-19 pandemic and predict that restrictive social distancing can reduce the widespread of coronavirus among the human. Sarkar and Khajanchi [@bib0014], [@bib0017] proposed and analyzed a mathematical model to study the transmission dynamics of COVID-19 or SARS-CoV-2, where they performed the model validation with real data from India and some provinces of India, respectively. Based on the estimated model parameters, the authors performed the short-term prediction as well as long-term prediction. Liu and colleagues [@bib0019] developed a mathematical model by considering reported and unreported cases to study the transmission dynamics of novel coronavirus by using data from China. To study the intervention strategies of infectious diseases in an extended version of the classical SEIR (susceptible-exposed-infected-recovered) model that incorporates the fact that asymptomatic and pre-symptomatic infected individuals are believed to play a key role in the transmission dynamics of COVID-19 outbreak [@bib0016].

Our aim of this paper is to propose a compartmental mathematical model by introducing reported and unreported symptomatic individuals based on the data from the Republic of India. We address the following important issues regarding the outbreak of COVID-19: how does the outbreak develop in India with respect to the number of reported and unreported cases ? When the epidemic will end from India ? How the basic reproduction number *R* ~0~ influence disease outbreak ?

The organization of this manuscript is as follows: in the [Section 2](#sec0002){ref-type="sec"} we propose the SAIU mathematical model and its schematic representation. The qualitative properties of the SAIU model is discussed in the [Section 3](#sec0003){ref-type="sec"}. In the same section, we perform local and global stability analysis of the disease free and endemic equilibrium point in terms of *R* ~0~. Also, we establish the criteria for the disease persistence with respect to *R* ~0~. In the [Section 4](#sec0012){ref-type="sec"}, we conduct a sensitivity analysis for the basic reproduction number *R* ~0~. Numerical simulations based on the estimated parameter values are presented in the [Section 5](#sec0013){ref-type="sec"}, and a discussion in the [Section 6](#sec0014){ref-type="sec"} concludes our manuscript.

2. Model formulation {#sec0002}
====================

Mathematical modeling of transmission dynamics of infectious diseases are now ubiquitous. A series of mathematical models has been investigated by many researchers to describe the interactive dynamics of infectious diseases [@bib0022], [@bib0023], [@bib0024]. We proposed here a deterministic ordinary differential equation model that can represent the overall dynamics of novel coronavirus or SARS-CoV-2. We stratified the total human population into four compartments, namely susceptible individuals (uninfected), asymptomatic individuals (pauci-symptomatic or clinically undetected), reported symptomatic infected individuals (symptomatic infectious individuals are reported by the public heath service) and unreported symptomatic infected individuals (clinically ill but not reported) to formulate the SAIU (susceptible or uninfected (*S*)  →  asymptomatic (*A*)  →  reported symptomatic infectious (*I*)  →  unreported symptomatic infectious (*U*)) model. The total size of the population is $N\left( t \right) = S\left( t \right) + A\left( t \right) + I\left( t \right) + U\left( t \right)$. We assume that the reported infected individuals will no-longer associate into the infections as they are isolated and move to the hospital or Intensive Care Units (ICU). Thus, only infectious individuals belonging to I(t) or U(t) - spread or transmit the diseases. The COVID-19 transmission is illustrated in the [Fig. 1](#fig0001){ref-type="fig"} . The model consists of the following set of nonlinear differential equations:$$\begin{array}{rcl}
\frac{dS\left( t \right)}{dt} & = & {\Lambda_{s} - \frac{\beta_{s}S\left( t \right)}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) - \mu S\left( t \right),} \\
\frac{dA\left( t \right)}{dt} & = & {\frac{\beta_{s}S\left( t \right)}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) - \gamma_{a}A\left( t \right) - \mu A\left( t \right),} \\
\frac{dI\left( t \right)}{dt} & = & {q_{i}\gamma_{a}A\left( t \right) - \eta_{i}I\left( t \right) - \mu I\left( t \right),} \\
\frac{dU\left( t \right)}{dt} & = & {\gamma_{a}\left( 1 - q_{i} \right)A\left( t \right) - \eta_{u}U\left( t \right) - \mu U\left( t \right),} \\
\end{array}$$ with the positive initial conditions:$${S\left( t_{0} \right)} = {S_{0},\mspace{6mu}\mspace{6mu}\mspace{6mu} A\left( t_{0} \right) = A_{0},\mspace{6mu}\mspace{6mu}\mspace{6mu} I\left( t_{0} \right) = I_{0}\mspace{6mu}\mspace{6mu}{and}\mspace{6mu}\mspace{6mu} U\left( t_{0} \right) = U_{0}.}$$ Fig. 1The schematic flow diagram represents the susceptible or uninfected (*S*), asymptomatic (*A*), reported symptomatic infectious (*I*) and unreported symptomatic infectious (*U*) individuals for novel coronavirus disease that persuades the formulation of the SAIU model [(1)](#eq0001){ref-type="disp-formula"}.Fig. 1

Here *t* ≥ *t* ~0~ represents the time in days, *t* ~0~ is the starting date for the model system [(1)](#eq0001){ref-type="disp-formula"} of the epidemic. Some of the parameters may alter in time as control measures are implemented or changed. We performed the theoretical analysis for the model with constant parameters. In our model, we introduce some demographic effects by considering a proportional natural decay rate *μ* \> 0 in each of the four individuals. In addition, our model includes a net inflow of susceptible or uninfected population at a rate Λ~*s*~ per unit time. The uninfected individuals can be decreased following infection, acquired by contact between an uninfected and an infected individual, who may be asymptomatic or unreported infected individuals. The transmission coefficients for these two compartments of infected populations are *β~s~α~a~* and *β~s~α~u~*, respectively. Here, we consider the disease transmission coefficient *β~s~* (which models both the contact rates and the infectiousness of novel coronavirus), with adjustment factors for asymptomatic individuals (*α~a~*) and unreported symptomatic infected individuals (*α~u~*). The effect of the parameters *β~s~α~a~* and *β~s~α~u~* are explicitly associated with the measures like lockdown, social distancing, restriction of movement and shaking hand etc., that actually decrease the number of contacts. Asymptomatic infectious populations develop to reported symptomatic infectious and unreported symptomatic infectious classes at a rate *γ~a~* with a fraction *q~i~* and $\left( 1 - q_{i} \right)$ respectively, that is, 0 \< *q~i~* \< 1. Thus, the average time spent in the asymptomatic infectious individuals is $\frac{1}{\gamma_{a}}$ days. The reported symptomatic infected populations (*I*) and the unreported symptomatic individuals (*U*) are infectious for an average period of $\frac{1}{\eta_{i} + \mu}$ days and $\frac{1}{\eta_{u} + \mu}$ days, respectively. In our model formulation, we assume that the reported symptomatic infectious individuals (*I*) are reported and hospitalized or isolated immediately, and thus no further infections. The asymptomatic infected class (*A*) can also be considered as having a lower-level symptomatic state.

Albeit, COVID-19 is supposed to be transmitted exclusively by reported symptomatic infectious individuals, a very low rate of transmission by asymptomatic populations cannot yet be ruled out. The SAIU model take into accounts for this probability by utilizing the adjustment parameter *α~a~*, where 0 \< *α~a~* \< 1. The adjustment parameter *α~u~* \> 0 accounts for varying levels of hygiene safeguards during quarantine. Because the quarantine and isolation or hospitalization programmes and hygiene safeguards during quarantine and isolation or hospitalization were implemented and increased continuously after an epidemic. All the infections are obtained from either asymptomatic (*A*) or unreported symptomatic infectious (*U*) individuals. The model parameters and their description are provided in the [Table 1](#tbl0001){ref-type="table"} and a schematic diagram for the SAIU model is given in the [Fig. 1](#fig0001){ref-type="fig"}.

3. Qualitative properties of the model {#sec0003}
======================================

3.1. Positive invariance {#sec0004}
------------------------

Here, we shall investigate that all the state variables of the system [(1)](#eq0001){ref-type="disp-formula"} are non-negative for all time *t* with initial conditions $\left( S\left( 0 \right),A\left( 0 \right),I\left( 0 \right),U\left( 0 \right) \right)\mspace{6mu} \in \mspace{6mu}\mathbb{R}_{+}^{4}$. In order to prove the positivity, we state the following theorem.Theorem 3.1*All the solutions (S(t), A(t), I(t), U(t)) of the system* [(1)](#eq0001){ref-type="disp-formula"} *with the initial values* [(2)](#eq0002){ref-type="disp-formula"} *satisfy S*(*t*) \> 0, *A*(*t*) \> 0, *I*(*t*) \> 0 *and U*(*t*) \> 0 *for all t* \> 0, *then the system* [(1)](#eq0001){ref-type="disp-formula"} *is positively invariant and attracting within* $\mathbb{R}_{+}^{4}$ *.* ProofThe first equation of the system [(1)](#eq0001){ref-type="disp-formula"}, can be written as$$\frac{dS\left( t \right)}{dt} = {\Lambda_{s} - \frac{\beta_{s}S\left( t \right)}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) - \mu S\left( t \right)} = {\Lambda_{s} - \psi_{1}\left( t \right)S\left( t \right),}$$ where$${\psi_{1}\left( t \right)} = {\frac{\beta_{s}}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) + \mu.}$$Thereafter by integration, we obtain the following expression$$\begin{array}{ccl}
{S\left( t \right)} & = & {S_{0}\exp\left( - \int_{0}^{t}\psi_{1}\left( s \right)ds \right)} \\
 & & {+ \,\Lambda_{s}\exp\left( - \int_{0}^{t}\psi_{1}\left( s \right)ds \right)\int_{0}^{t}e^{\int_{0}^{s}\psi_{1}{(u)}du}ds > \mspace{6mu} 0.} \\
\end{array}$$This shows that *S*(*t*) is nonnegative for all *t*. Further from the second equation of the system [(1)](#eq0001){ref-type="disp-formula"}, we have$$\frac{dA\left( t \right)}{dt} \geq {- \left( \gamma_{a} + \mu \right)A\left( t \right),}$$ which gives$${A\left( t \right)} = {A_{0}\exp\left( - \int_{0}^{t}\left( \gamma_{a} + \mu \right)ds \right)\mspace{6mu} > \mspace{6mu} 0.}$$Similarly, from the third equation of the system [(1)](#eq0001){ref-type="disp-formula"}, we get$$\frac{dI\left( t \right)}{dt} \geq {- \left( \eta_{i} + \mu \right)I\left( t \right),}$$ and this inequality implies$${I\left( t \right)} = {I_{0}\mspace{6mu}\exp\left( - \int_{0}^{t}\left( \eta_{i} + \mu \right)ds \right)\mspace{6mu} > \mspace{6mu} 0.}$$In the similar way, the last equation of the system [(1)](#eq0001){ref-type="disp-formula"} gives$$\frac{dU\left( t \right)}{dt} \geq {- \left( \eta_{u} - \mu \right)U\left( t \right),}$$ which leads to$${U\left( t \right)} = {U_{0}\mspace{6mu}\exp\left( - \int_{0}^{t}\left( \eta_{u} + \mu \right)ds \right)\mspace{6mu} > \mspace{6mu} 0.}$$From the above analysis, we can conclude that all the solution trajectories of the system [(1)](#eq0001){ref-type="disp-formula"} remain positive for all *t* \> 0. Hence the proof. □

3.2. Boundedness {#sec0005}
----------------

Now we start with the theorem which assure that the solutions of the system [(1)](#eq0001){ref-type="disp-formula"} is bounded with nonnegative initial values.Theorem 3.2*The solutions of the system* [(1)](#eq0001){ref-type="disp-formula"} *with the initial conditions* [(2)](#eq0002){ref-type="disp-formula"} *which initiate in* $\mathbb{R}_{+}^{4}$ *are uniformly bounded in the positively invariant set* Φ*.* ProofHere, we will show that all the feasible solutions are uniformly bounded in Φ. From the positivity of solutions, we get$$\frac{dS\left( t \right)}{dt} \leq {\Lambda_{s} - \mu S\left( t \right),}$$ which implies that$${\operatorname{lim\ sup}\limits_{t\rightarrow\infty}S\left( t \right)} \leq {\frac{\Lambda_{s}}{\mu}.}$$Taking $\mu = \min\left\{ \mu,\eta_{i} + \mu,\eta_{u} + \mu \right\},$ we obtain$$\frac{dN\left( t \right)}{dt} \leq {\Lambda_{s} - \mu N\left( t \right),}$$ which gives$${\operatorname{lim\ sup}\limits_{t\rightarrow\infty}N\left( t \right)} \leq {\frac{\Lambda_{s}}{\mu}.}$$Accordingly, we obtain the following positively invariant bounded region$$\Phi = {\left\{ \left( S\left( t \right),A\left( t \right),I\left( t \right),U\left( t \right) \right) \in \mathbb{R}_{+}^{4} \mid \mspace{6mu} S\left( t \right) + A\left( t \right) + I\left( t \right) + U\left( t \right)\mspace{6mu} \leq \mspace{6mu}\frac{\Lambda_{s}}{\mu} \right\}.}$$Therefore, all the solution trajectories initiating in $\mathbb{R}_{+}^{4}$ will enter Φ with finite time. In the region Φ, the existence, uniqueness and continuity results hold the dynamics of our SAIU model system [@bib0025], [@bib37]. Hence the system is well-posed and biologically realistic. □

3.3. Basic reproduction number {#sec0006}
------------------------------

The basic reproduction number for the SAIU model can be determined by using the next generation matrix introduced by van den Driessche and Watmough [@bib0026]. In order to do this, we consider the nonnegative matrix $\mathcal{F}$ and the non-singular M-matrix $\mathcal{V}$ expressing the production of new-infection and transition part, respectively. Our SAIU model system [(1)](#eq0001){ref-type="disp-formula"} is defined as follows:$$\begin{array}{ccl}
\mathcal{F} & = & \left\lbrack \begin{array}{l}
{\beta_{s}\frac{S\left( t \right)}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right)} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
\end{array} \right\rbrack \\
 & & {{and}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mathcal{V} = \left\lbrack \begin{array}{l}
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( \gamma_{a} + \mu \right)A\left( t \right)} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} - q_{i}\gamma_{a}A\left( t \right) + \left( \eta_{i} + \mu \right)I\left( t \right)} \\
{- \left( 1 - q_{i} \right)\gamma_{a}A\left( t \right) + \left( \eta_{u} + \mu \right)U\left( t \right)} \\
\end{array} \right\rbrack.} \\
\end{array}$$

Now, *F* and *V* can be written as$$F = \left( \begin{array}{lll}
{\beta_{s}\alpha_{a}} & {\mspace{6mu} 0} & {\beta_{s}\alpha_{u}} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
\end{array} \right)\mspace{6mu}\mspace{6mu}{and}\mspace{6mu}\mspace{6mu} V = \left( \begin{array}{lll}
{\mspace{6mu}\mspace{6mu}\gamma_{a} + \mu} & {\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu} - q_{i}\gamma_{a}} & {\eta_{i} + \mu} & {\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{- \left( 1 - q_{i} \right)\gamma_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\eta_{u} + \mu} \\
\end{array} \right).$$

The basic reproduction number denoted by *R* ~0~ is the spectral radius of the next generation matrix:$$R_{0} = {\rho\left( FV^{- 1} \right) = \frac{\beta_{s}\alpha_{a}}{\gamma_{a} + \mu} + \frac{\beta_{s}\alpha_{u}\gamma_{a}\left( 1 - q_{i} \right)}{\left( \gamma_{a} + \mu \right)\left( \eta_{u} + \mu \right)}.}$$

3.4. Stability analysis of disease-free equilibrium (DFE) {#sec0007}
---------------------------------------------------------

Theorem 3.3*The disease-free equilibrium point E* ~0~(Λ~*s*~/*μ*, 0, 0, 0) *exists and is locally asymptotically stable for R* ~0~ \< 1, *otherwise unstable.* ProofTo determine the local stability of *E* ~0~(Λ~*s*~/*μ*, 0, 0, 0), we compute the Jacobian matrix of the system [(1)](#eq0001){ref-type="disp-formula"} around the DFE *E* ~0~ is given by$$J_{E_{0}} = \left( \begin{array}{clll}
{- \mu} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} - \beta_{s}\alpha_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {- \beta_{s}\alpha_{u}} \\
 & & & \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\beta_{s}\alpha_{a} - \left( \gamma_{a} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\beta_{s}\alpha_{u}} \\
 & & & \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} q_{i}\gamma_{a}} & {- \left( \eta_{i} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
 & & & \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( 1 - q_{i} \right)\gamma_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {- \left( \eta_{u} + \mu \right)} \\
\end{array} \right).$$The characteristic equation of $J_{E_{0}}$corresponding to the eigenvalue *λ* is $det\left( J_{E_{0}} - \lambda I_{4} \right)\mspace{6mu} = \mspace{6mu} 0$. From the characteristics equation, two eigenvalues of $J_{E_{0}}$ are real and negative, that is, $- \mu$ and $- \left( \eta_{i} + \mu \right)$ (since all parameters are positive) and the other two eigenvalues can be obtained form the following equation$${\lambda^{2} + \rho_{1}\lambda + \rho_{2}} = {0,}$$ where$$\begin{array}{rcl}
\rho_{1} & = & {2\mu + \gamma_{a} + \gamma_{u} - \beta_{s}\alpha_{a},} \\
\rho_{2} & = & {\left( \eta_{u} + \mu \right)\left( \gamma_{a} + \mu \right)\left( 1 - R_{0} \right).} \\
\end{array}$$Here, we observe that *ρ* ~2~ \> 0, this implies *ρ* ~1~ \> 0. Therefore, the quadratic [Eq. (4)](#eq0004){ref-type="disp-formula"} has two strictly negative real roots or negative real parts if *ρ* ~2~ \> 0, that is, if *R* ~0~  \< 1 . Hence, disease-free equilibrium point (DFE) is locally asymptotically stable if *R* ~0~ \< 1 and unstable for *R* ~0~  \>  1. □

3.5. Global stability analysis of disease-free equilibrium (DFE) {#sec0008}
----------------------------------------------------------------

In this subsection, we study the global stability of the unique disease-free equilibrium point *E* ~0~ with the condition *R* ~0~ \< 1. In order to do this, we use a Lyapunov function similar to those are very classic and used by Korobeinikov & Maini [@bib0027], Mcclusky [@bib0028], and Khajanchi & Banerjee [@bib0029]. Such Lyapunov function take an advantages of all the properties of the function:$$r\left( m \right) = m - 1 - \ln\left( m \right).$$ which is nonnegative in $\mathbb{R}_{+}^{4}$ except at $m = 1,$ where it become zero. Now, we prove the global stability for *E* ~0~ by using the following Theorem.Theorem 3.4*The disease-free equilibrium E* ~0~ *of the SAIU system* [(1)](#eq0001){ref-type="disp-formula"} *is globally asymptotically stable if R* ~0~ \< 1 *and* $\beta_{s}\alpha_{u} < \eta_{i} + \mu < \beta_{s}\alpha_{u}\left( 1 - q_{i} \right)$ *.* ProofConsider the following Lyapunov function$$V_{E_{0}}\left( S\left( t \right),A\left( t \right),I\left( t \right),U\left( t \right) \right) = S_{0}r\left( \frac{S\left( t \right)}{S_{0}} \right) + A\left( t \right) + I\left( t \right) + U\left( t \right).$$Here $V_{E_{0}}$ is always nonnegative in the region Φ and attains zero at *E* ~0~. We want to show that ${\overset{˙}{V}}_{E_{0}}$ is negative definite. Differentiate $V_{E_{0}}$ along the solution trajectory is given by$$\begin{array}{ccl}
\overset{˙}{V_{E_{0}}} & = & {\left( 1 - \frac{S_{0}}{S\left( t \right)} \right)\overset{˙}{S}\left( t \right) + \overset{˙}{A}\left( t \right) + \overset{˙}{I}\left( t \right) + \overset{˙}{U}\left( t \right)} \\
 & = & {\left( 1 - \frac{S_{0}}{S\left( t \right)} \right)\left( \Lambda_{s} - \frac{\beta_{s}S\left( t \right)}{N}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) - \mu S\left( t \right) \right) + \frac{\beta_{s}S\left( t \right)}{N}\left( \alpha_{a}A\left( t \right) \right.} \\
 & & {\left. + \alpha_{u}U\left( t \right) \right) - \left( \gamma_{a} + \mu \right)A\left( t \right) + q_{i}\gamma_{a}A\left( t \right) - \left( \eta_{i} + \mu \right)I\left( t \right) + \gamma_{a}\left( 1 - q_{i} \right)A\left( t \right)} \\
 & & {- \left( \eta_{u} + \mu \right)U\left( t \right),} \\
 & = & {\Lambda_{s} - \frac{\beta_{s}S\left( t \right)}{N}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right) - \mu S\left( t \right) - \Lambda_{s}\frac{S_{0}}{S\left( t \right)} + \beta_{s}\alpha_{a}\frac{S_{0}A\left( t \right)}{N}} \\
 & & {+ \beta_{s}\alpha_{u}\frac{S_{0}U\left( t \right)}{N} + \mu S_{0} + \frac{\beta_{s}S\left( t \right)}{N}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right)} \\
 & & \\
 & & {- \left( \gamma_{a} + \mu \right)A\left( t \right) + q_{i}\gamma_{a}A\left( t \right) - \left( \eta_{i} + \mu \right)I\left( t \right) + \gamma_{a}\left( 1 - q_{i} \right)A\left( t \right) - \left( \eta_{u} + \mu \right)U\left( t \right),} \\
 & = & {\mu S_{0} - \mu S - \frac{S_{0}}{S\left( t \right)}\left( \mu S_{0} \right) + \beta_{s}\alpha_{a}\frac{S_{0}A\left( t \right)}{N} + \beta_{s}\alpha_{u}\frac{S_{0}U\left( t \right)}{N} + \mu S_{0} - \left( \gamma_{a} + \mu \right)A\left( t \right)} \\
 & & {+ q_{i}\gamma_{a}A\left( t \right) - \left( \eta_{i} + \mu \right)I\left( t \right) + \gamma_{a}\left( 1 - q_{i} \right)A\left( t \right) - \left( \eta_{u} + \mu \right)U\left( t \right),} \\
 & = & {\mu S_{0}\left( 2 - \frac{S_{0}}{S\left( t \right)} - \frac{S\left( t \right)}{S_{0}} \right) + \left( \gamma_{a} + \mu \right)A\left( t \right)\left( R_{0} - 1 \right) + \left( \beta_{s}\alpha_{u} - \left( \eta_{u} + \mu \right) \right)U\left( t \right)} \\
 & & {+ \gamma_{a}\left( 1 - \frac{\left( 1 - q_{i} \right)\beta_{s}\alpha_{u}}{\eta_{u} + \mu} \right)A\left( t \right) - \left( \eta_{u} + \mu \right)I\left( t \right).} \\
\end{array}$$$\overset{˙}{V_{E_{0}}} < 0$ if (i) *R* ~0~ \< 1 and (ii) $\beta_{s}\alpha_{u} < \eta_{i} + \mu < \beta_{s}\alpha_{u}\left( 1 - q_{i} \right),$ with the aid of the relation between the arithmetic means and geometric means, we ensure that ${\overset{˙}{V}}_{E_{0}} \leq 0$ and the equality holds only at *E* ~0~. Hence, the disease-free equilibrium point *E* ~0~ is globally asymptotically stable if *R* ~0~ \< 1. □

3.6. Persistence of the coronavirus disease {#sec0009}
-------------------------------------------

In the [Theorem 3.3](#enun0003){ref-type="statement"}, we proved that while basic reproduction number *R* ~0~  \<  1, the coronavirus disease dies out irrespective of the initial size of the epidemic. If *R* ~0~  \>  1 the disease-free equilibrium *E* ~0~ become unstable. Usually it is considered that the infected individuals *A*(*t*), *I*(*t*) and *U*(*t*) will remain persistent for this event. Now, we prove the following theorem to verify the persistence of the coronavirus diseases.Theorem 3.5*Assume that R* ~0~ \> 1*. The disease will be uniformly persistent in the sense that there exists an* ϱ \> 0, *such that for every positive solution of the system* [(1)](#eq0001){ref-type="disp-formula"} *, holds the following* $${\lim\,\text{inf}}_{t\rightarrow\infty}A\left( t \right) > \varrho,\quad{\lim\,\text{inf}}_{t\rightarrow\infty}I\left( t \right) > \varrho\quad{and}\quad{\lim\,\text{inf}}_{t\rightarrow\infty}U\left( t \right) > \varrho.$$*Also, there exists an endemic equilibrium point in this case.* ProofAccording to the theorem by Thieme [@bib0030], we prove the uniform persistance. In order to prove this, we consider that$$\begin{array}{rcl}
Q & = & {\left( S\left( t \right),A\left( t \right),I\left( t \right),U\left( t \right) \right),\overline{Q} = \left( A\left( t \right),I\left( t \right),U\left( t \right) \right),} \\
G & = & {\left\{ Q_{j} \in \mathbb{R}_{+}^{4}|Q_{j} \geq 0,j = 1,...,4,\mspace{6mu}{where}\mspace{6mu} Q_{j}\mspace{6mu}{{is}\mspace{6mu}\text{the}\mspace{6mu} j^{\prime}\text{th}\mspace{6mu}\text{component}\mspace{6mu}\text{of}}\mspace{6mu} Q \right\},} \\
G_{0} & = & {\left. \left\{ Q \in G \right|Q_{j}\mspace{6mu} > \mspace{6mu} 0,j = 2,3,4 \right\},} \\
H & = & {\left. G/G_{0}{= \left\{ Q \in G \right|}Q_{j} = 0,\mspace{6mu}{{for}\mspace{6mu}\text{some}}\mspace{6mu} j = 2,3,4 \right\}.} \\
\end{array}$$Now, we want to show that the system [(1)](#eq0001){ref-type="disp-formula"} is uniformly persistent with respect to (*G* ~0~, *H*). Since *H* contains a unique equilibrium *E* ~0~, it is sufficient to show that $W^{s}\left( E_{0} \right)\bigcap G_{0} = \phi,$ where *W^s^*(*E* ~0~) denotes the stable manifold of the disease-free equilibrium *E* ~0~.Suppose this is not true. Then there is a solution (*S*(*t*), *A*(*t*), *I*(*t*), *U*(*t*)) ∈ *G* ~0~ of the system [(1)](#eq0001){ref-type="disp-formula"}, such that$$\left. \lim\limits_{t\rightarrow\infty}\left( S\left( t \right),A\left( t \right),I\left( t \right),U\left( t \right) \right)\rightarrow\left( \Lambda_{s}/\mu,0,0,0 \right). \right.$$Then for any ε \> 0, we obtain$$\frac{\Lambda_{s}}{\mu} - \varepsilon \leq S\left( t \right) \leq \frac{\Lambda_{s}}{\mu} + \varepsilon,\mspace{6mu}\mspace{6mu}\mspace{6mu} 0 \leq Q_{j} \leq \varepsilon,\mspace{6mu} j = 2,3,4,$$ for sufficiently large value of *t*. From the following the system [(1)](#eq0001){ref-type="disp-formula"}, we have$$\left( \begin{array}{l}
\frac{dA\left( t \right)}{dt} \\
\frac{dI\left( t \right)}{dt} \\
\frac{dU\left( t \right)}{dt} \\
\end{array} \right) = \left( \begin{array}{l}
{\beta_{s}\frac{S\left( t \right)}{N\left( t \right)}\left( \alpha_{a}A\left( t \right) + \alpha_{u}U\left( t \right) \right)} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
\end{array} \right)$$ $$+ \left( \begin{array}{l}
{- \left( \gamma_{a} + \mu \right)\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} q_{i}\gamma_{a} - \left( \eta_{i} + \mu \right)\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\left( 1 - q_{i} \right)\gamma_{a}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0 - \left( \eta_{u} + \mu \right)} \\
\end{array} \right)\left( \begin{array}{l}
{A\left( t \right)} \\
{I\left( t \right)} \\
{U\left( t \right)} \\
\end{array} \right)$$ $$\geq \left( \begin{array}{l}
{\beta_{s}\alpha_{a}\widetilde{S}\left( \varepsilon \right) - \left( \gamma_{a} + \mu \right)\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0\beta_{s}\alpha_{u}\widetilde{S}\left( \varepsilon \right)} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} q_{i}\gamma_{a} - \left( \eta_{i} + \mu \right)\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( 1 - q_{i} \right)\gamma_{a}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0 - \left( \eta_{u} + \mu \right)} \\
\end{array} \right)\left( \begin{array}{l}
{A\left( t \right)} \\
{I\left( t \right)} \\
{U\left( t \right)} \\
\end{array} \right) \equiv \widetilde{J}\left( \varepsilon \right)\overline{Q},$$ where$$\widetilde{S}\left( \varepsilon \right) = \frac{\Lambda_{s}/\mu - \varepsilon}{\Lambda_{s}/\mu + \varepsilon},$$ and$$\widetilde{J}\left( 0 \right) = \left( \begin{array}{lll}
{\beta_{s}\alpha_{a} - \left( \gamma_{a} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\beta_{s}\alpha_{u}} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} q_{i}\gamma_{a}} & {- \left( \eta_{i} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( 1 - q_{i} \right)\gamma_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {- \left( \eta_{u} + \mu \right)} \\
\end{array} \right).$$Note that, $\widetilde{J}\left( 0 \right)$ is equal to $\left( F - V \right),$ has at least one eigenvalue with positive real part when *R* ~0~ \> 1. Therefore, ε \> 0 is arbitrary, one can make ε small enough so that $x\left( \widetilde{J}\left( \varepsilon \right) \right)$ is positive, where *x*(*B*) is the largest real part of the eigenvalue of B. So there exist solutions of the linear system$$\frac{d\overline{Q}}{dt} = {\widetilde{J}\left( \varepsilon \right)\overline{Q},}$$ which can grow exponentially. By comparison, the solutions Q become unbounded as *t* → ∞. This gives a contradiction to our assumption that the solutions of the model [(1)](#eq0001){ref-type="disp-formula"} are uniformly bounded. Hence, $W^{s}\left( E_{0} \right)\bigcap G_{0} = \phi$. By using the Theorem 4.6 in [@bib0030], it can be concluded that the system [(1)](#eq0001){ref-type="disp-formula"} is uniformly persistent with respect to (*G* ~0~, *H*).Therefore, the system of [Eqs. (1)](#eq0001){ref-type="disp-formula"} are dissipative (showed in the Theorem 2) and thus by using the [Theorem 3.3](#enun0003){ref-type="statement"} in [@bib0031] indicates that the model system [(1)](#eq0001){ref-type="disp-formula"} has an interior equilibrium point (that is, all components are positive). This completes the proof of this theorem. □

3.7. Existence of an endemic equilibrium point {#sec0010}
----------------------------------------------

The SAIU model system [(1)](#eq0001){ref-type="disp-formula"} has an endemic equilibrium point *E*\*(*S*\*, *A*\*, *I*\*, *U*\*) with positive components provided *R* ~0~ \> 1. Equating the derivatives of the model system [(1)](#eq0001){ref-type="disp-formula"} to zero and solving the resulting equations. First, we define$$\kappa^{*} = \frac{\beta_{s}}{N^{*}\left( t \right)}\left\lbrack \alpha_{a}A^{*}\left( t \right) + \alpha_{u}U^{*}\left( t \right) \right\rbrack.$$

By solving the equations in the system [(1)](#eq0001){ref-type="disp-formula"} at endemic steady state, we obtain that$$\begin{array}{rcl}
S^{*} & = & {\frac{\Lambda_{s}}{\left( \kappa^{*} + \mu \right)},\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} I^{*} = \frac{\Lambda_{s}q_{i}\gamma_{a}\kappa^{*}}{\left( \gamma_{a} + \mu \right)\left( \eta_{i} + \mu \right)\left( \kappa^{*} + \mu \right)},} \\
A^{*} & = & {\frac{\Lambda_{s}\kappa^{*}}{\left( \gamma_{a} + \mu \right)\left( \kappa^{*} + \mu \right)},\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} U^{*} = \frac{\left( 1 - q_{i} \right)\Lambda_{s}\gamma_{a}\kappa^{*}}{\left( \gamma_{a} + \mu \right)\left( \eta_{u} + \mu \right)\left( \kappa^{*} + \mu \right)}.} \\
\end{array}$$

Plugging the above expression [(7)](#eq0007){ref-type="disp-formula"} into the [Eq. (6)](#eq0006){ref-type="disp-formula"}, we obtain the nonzero equilibrium of the system [(1)](#eq0001){ref-type="disp-formula"} satisfying the linear equation, in terms of *κ*\* as follows:$$\Upsilon_{1}\kappa^{*} + \Upsilon_{2} = 0,$$ where$$\begin{array}{rcl}
\Upsilon_{1} & = & {\left( \eta_{i} + \mu \right)\left( \eta_{u} + \mu \right) + q_{i}\gamma_{a}\left( \eta_{u} + \mu \right) + \left( 1 - q_{i} \right)\gamma_{a}\left( \eta_{i} + \mu \right),} \\
\Upsilon_{2} & = & {\left( \gamma_{a} + \mu \right)\left( \eta_{i} + \mu \right)\left( \eta_{u} + \mu \right)\left( 1 - R_{0} \right).} \\
\end{array}$$

Clearly, Υ~1~  \>  0 as $\gamma_{a} + \mu$  \>  0, $\eta_{i} + \mu$  \>  0, and $\eta_{u} + \mu$  \>  0, hence we can say that the system [(1)](#eq0001){ref-type="disp-formula"} has a unique positive endemic equilibrium point whenever *R* ~0~ \> 1 and no positive equilibrium point whenever *R* ~0~ \< 1.Theorem 3.6*The endemic equilibrium E*\* *of the system* [(1)](#eq0001){ref-type="disp-formula"} *is locally asymptotically stable if R* ~0~ \> 1*.* ProofIntroducing $x_{1} = S\left( t \right),x_{2} = A\left( t \right),x_{3} = I\left( t \right)$ and $x_{4} = U\left( t \right),$ then the system [(1)](#eq0001){ref-type="disp-formula"} becomes$$\begin{array}{rcl}
\frac{dx_{1}}{dt} & = & {\Lambda_{s} - \frac{\beta_{s}x_{1}}{N}\left( \alpha_{a}x_{2} + \alpha_{u}x_{4} \right) - \mu x_{1} \equiv q_{1},} \\
\frac{dx_{2}}{dt} & = & {\frac{\beta_{s}x_{1}}{N}\left( \alpha_{a}x_{2} + \alpha_{u}x_{4} \right) - \gamma_{a}x_{2} - \mu x_{2} \equiv q_{2},} \\
\frac{dx_{3}}{dt} & = & {q_{i}\gamma_{a}x_{2} - \eta_{i}x_{3} - \mu x_{3} \equiv q_{3},} \\
\frac{dx_{4}}{dt} & = & {\left( 1 - q_{i} \right)\gamma_{a}x_{2} - \eta_{u}x_{4} - \mu x_{4} \equiv q_{4},} \\
\end{array}$$ with $R_{0} = 1,$ and choosing the bifurcation parameter *β~s~*.The Jacobian matrix of the system [(9)](#eq0009){ref-type="disp-formula"} around the disease free equilibrium *E* ~0~ at the threshold point $\beta_{s} = \beta_{s}^{*} = \frac{\left( \gamma_{a} + \mu \right)\left( \eta_{u} + \mu \right)}{\left( \eta_{u} + \mu \right)\alpha_{a} + \alpha_{u}\left( 1 - q_{i} \right)\gamma_{a}}$ is given by$$J_{E_{0}}^{*} = \left( \begin{array}{llll}
{- \mu} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} - \beta_{s}^{*}\alpha_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {- \beta_{s}^{*}\alpha_{u}} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\beta_{s}^{*}\alpha_{a} - \left( \gamma_{a} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\beta_{s}^{*}\alpha_{u}} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} q_{i}\gamma_{a}} & {- \left( \eta_{i} + \mu \right)} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} \\
{\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\left( 1 - q_{i} \right)\gamma_{a}} & {\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0} & {- \left( \eta_{u} + \mu \right)} \\
\end{array} \right).$$The eigenvalues of the $J_{E_{0}}^{*}$ are $- \mu,$ $- \left( \eta_{u} + \mu \right),$ $\left( 2\mu + \gamma_{a} + \gamma_{u} - \beta_{s}^{*}\alpha_{a} \right)$ and 0. Here 0 is the simple eigenvalue of $J_{E_{0}}^{*}$ and the others eigenvalues have negative real parts. Hence, the Center Manifold Theorem can be applied and we get a right eigenvector and a left eigenvector corresponding to the zero-eigenvalue is given by$$v = \left\lbrack - R_{0}\left( 1 + \frac{\gamma_{a}}{\mu} \right)\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 1\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\frac{q_{i}\gamma_{a}}{\eta_{i} + \mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\frac{\left( 1 - q_{i} \right)\gamma_{a}}{\eta_{u} + \mu} \right\rbrack{}^{T}v_{2},$$ and$$u = \left\lbrack 0\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 1\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu} 0\mspace{6mu}\mspace{6mu}\mspace{6mu}\mspace{6mu}\frac{\beta_{s}^{*}\alpha_{u}}{\eta_{u} + \mu} \right\rbrack u_{2}.s$$Hence, we have$$a = {\sum\limits_{k,i,j = 1}^{4}u_{k}v_{i}v_{j}\left\lbrack \frac{\partial^{2}q_{k}}{\partial x_{i}\partial x_{j}}\left( E_{0} \right) \right\rbrack\mspace{6mu}\mspace{6mu}{and}\mspace{6mu}\mspace{6mu} b = \sum\limits_{k,i = 1}^{4}u_{k}v_{i}\left\lbrack \frac{\partial^{2}q_{k}}{\partial x_{i}\partial\beta_{s}^{*}}\left( E_{0} \right) \right\rbrack,}$$ whose sign determined the local stability criteria of the endemic equilibrium point *E*\*. Substituting the values of all second-order derivatives measured at DFE, *E* ~0~ is given by$$a = {2\left\lbrack v_{1}v_{2}\frac{\partial^{2}q_{2}}{\partial x_{1}\partial x_{2}} + v_{1}v_{4}\frac{\partial^{2}q_{2}}{\partial x_{1}\partial x_{4}} \right\rbrack u_{2},} = {- 2R_{0}\left( 1 + \frac{\gamma_{a}}{\mu} \right)\left\lbrack \beta_{s}^{*}\alpha_{a} + \frac{\gamma_{a}\left( 1 - q_{i} \right)}{\eta_{u} + \mu} \right\rbrack u_{2}v_{2} < 0,}$$ and$$b = {\left\lbrack v_{2}\frac{\partial^{2}q_{2}}{\partial x_{2}\partial\beta_{s}^{*}} + v_{4}\frac{\partial^{2}q_{2}}{\partial x_{4}\partial\beta_{s}^{*}} \right\rbrack u_{2},} = {\frac{R_{0}\left( \gamma_{a} + \mu \right)}{\beta_{s}^{*}}x_{1}u_{2}v_{2} > 0.}$$Therefore, *a* \< 0 and *b* \> 0 at $\beta_{s} = \beta_{s}^{*},$ a transcritical bifurcation occurs at $R_{0} = 1$ and unique endemic equilibrium is locally asymptotically stable for *R* ~0~ \> 1. □

3.8. Global stability of endemic equilibrium point {#sec0011}
--------------------------------------------------

This subsection is dealing with the global stability of an unique endemic equilibrium point *E*\* with the condition *R* ~0~ \> 1. In order to show that, we use the Lyapunov functional similar to the [Eq. (5)](#eq0005){ref-type="disp-formula"} and such Lyapunov functional take advantages of all the properties of the function. Now, we prove the following result.Theorem 3.7*The endemic equilibrium point E*\* *of the system* [(1)](#eq0001){ref-type="disp-formula"} *is exists and globally asymptotically stable if R* ~0~ \> 1*.* ProofLet us assume that *E*\* exists and the following function is well defined in $\mathbb{R}_{+}^{4}$. Now, we consider the following Lyapunov functional [@bib0032] as$$V_{E^{*}}\left( S,A,I,U \right) = S^{*}r\left( \frac{S}{S^{*}} \right) + A^{*}r\left( \frac{A}{A^{*}} \right) + I^{*}r\left( \frac{I}{I^{*}} \right) + U^{*}r\left( \frac{U}{U^{*}} \right).$$We need to show that ${\overset{˙}{V}}_{E^{*}}$ is negative definite. Differentiating $V_{E^{*}}$ along the solution trajectories of the system [(1)](#eq0001){ref-type="disp-formula"}, we get$$\begin{array}{r}
{{\overset{˙}{V}}_{E^{*}} = \left( 1 - \frac{S^{*}}{S} \right)\overset{˙}{S} + \left( 1 - \frac{A^{*}}{A} \right)\overset{˙}{A} + \left( 1 - \frac{I^{*}}{I} \right)\overset{˙}{I} + \left( 1 - \frac{U^{*}}{U} \right)\overset{˙}{U}} \\
{= \left( 1 - \frac{S^{*}}{S} \right)\left( \Lambda_{s} - \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) - \mu S \right) + \left( 1 - \frac{A^{*}}{A} \right)\left( \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) \right.} \\
{\left. - \left( \gamma_{a} + \mu \right)A \right) + \left( 1 - \frac{I^{*}}{I} \right)\left( q_{i}\gamma_{a}A - \left( \eta_{i} + \mu \right)I \right)} \\
{+ \left( 1 - \frac{U^{*}}{U} \right)\left( \gamma_{a}\left( 1 - q_{i} \right)A - \left( \eta_{u} + \mu \right)U \right),} \\
{= \Lambda_{s} - \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) - \mu S - \Lambda_{s}\frac{S^{*}}{S} + \beta_{s}\alpha_{a}\frac{S^{*}A}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U}{N} + \mu S^{*}} \\
{+ \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) - \left( \gamma_{a} + \mu \right)A - \beta_{s}\alpha_{a}\frac{SA^{*}}{N} - \beta_{s}\alpha_{u}\frac{SA^{*}U}{NA} + \left( \gamma_{a} + \mu \right)A^{*}} \\
{+ q_{i}\gamma_{a}A - \left( \eta_{i} + \mu \right)I - q_{i}\gamma_{a}\frac{AI^{*}}{I} + \left( \eta_{i} + \mu \right)I^{*} + \left( 1 - q_{i} \right)\gamma_{a}A - \left( \eta_{u} + \mu \right)U} \\
{- \left( 1 - q_{i} \right)\gamma_{a}\frac{AU^{*}}{U} + \left( \eta_{u} + \mu \right)U^{*},} \\
\end{array}$$ $$\begin{array}{r}
{= \beta_{s}\alpha_{a}\frac{S^{*}A^{*}}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U^{*}}{N} + \mu S^{*} - \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) - \mu S} \\
{- \frac{S^{*}}{S}\left( \beta_{s}\alpha_{a}\frac{S^{*}A^{*}}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U^{*}}{N} + \mu S^{*} \right) + \beta_{s}\alpha_{a}\frac{S^{*}A}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U}{N} + \mu S^{*}} \\
{+ \frac{\beta_{s}S}{N}\left( \alpha_{a}A + \alpha_{u}U \right) - \left( \gamma_{a} + \mu \right)A - \beta_{s}\alpha_{a}\frac{SA^{*}}{N} - \beta_{s}\alpha_{u}\frac{SA^{*}U}{N} + \left( \gamma_{a} + \mu \right)A^{*}} \\
{+ q_{i}\gamma_{a}A - q_{i}\gamma_{a}\frac{I}{I^{*}} - q_{i}\gamma_{a}\frac{A^{*}I}{I^{*}} + q_{i}\gamma_{a}A^{*} + \left( 1 - q_{i} \right)\gamma_{a}A - \left( 1 - q_{i} \right)\gamma_{a}\frac{A^{*}U}{U^{*}}} \\
{- \left( 1 - q_{i} \right)\gamma_{a}\frac{AU^{*}}{U} + \left( 1 - q_{i} \right)\gamma_{a}A^{*},} \\
\end{array}$$ $$\begin{array}{r}
{= 2\beta_{s}\alpha_{a}\frac{S^{*}A^{*}}{N} + 2\beta_{s}\alpha_{u}\frac{S^{*}U^{*}}{N} + 2\mu S^{*} - \frac{S^{*}}{S}\left( \beta_{s}\alpha_{a}\frac{S^{*}A^{*}}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U^{*}}{N} + \mu S^{*} \right)} \\
{+ \beta_{s}\alpha_{a}\frac{S^{*}A}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U}{N} - \left( \gamma_{a} + \mu \right)A - \beta_{s}\alpha_{a}\frac{SA^{*}}{N} - \beta_{s}\alpha_{u}\frac{SUA^{*}}{NA} + \gamma_{a}} \\
{+ \gamma_{a}A^{*} - q_{i}\gamma_{a}\frac{I}{I^{*}} - q_{i}\gamma_{a}\frac{A^{*}I}{I^{*}} - \left( 1 - q_{i} \right)\gamma_{a}\frac{A^{*}U}{U^{*}} - \left( 1 - q_{i} \right)\gamma_{a}\frac{AU^{*}}{U},} \\
\end{array}$$ $$\begin{array}{r}
{= \left( \mu S^{*} + \beta_{s}\alpha_{a}\frac{S^{*}A^{*}}{N} \right)\left( 2 - \frac{S^{*}}{S} - \frac{S}{S^{*}} \right) + \left( \beta_{s}\alpha_{u}\frac{S^{*}U^{*}}{N} \right)\left( 2 - \frac{S^{*}}{S} - \frac{SU}{S^{*}U^{*}} \right)} \\
{+ \beta_{s}\alpha_{a}\frac{S^{*}A}{N} + \beta_{s}\alpha_{u}\frac{S^{*}U}{N} - \gamma_{a}A - q_{i}\gamma_{a}\frac{I}{I^{*}} - q_{i}\gamma_{a}\frac{A^{*}I}{I^{*}} - \left( 1 - q_{i} \right)\gamma_{a}\frac{A^{*}U}{U^{*}}} \\
{- \left( 1 - q_{i} \right)\gamma_{a}\frac{AU^{*}}{U}.} \\
\end{array}$$Considering the relation of arithmetic means and geometric means, we ensure that ${\overset{˙}{V}}_{E^{*}} \leq 0$ and holds the equality only at *E*\*. Hence, the endemic equilibrium point *E*\* is globally asymptotically stable. □

4. Sensitivity analysis {#sec0012}
=======================

To determine how best to decrease human impermanence and morbidity due to COVID-19, it is essential to understand the relative importance of the various factors responsible for its transmission. Initial disease transmission is directly associated to the basic reproduction number *R* ~0~. We compute the sensitivity indices of the basic reproductive number *R* ~0~ to the parameters in the model. These indices allow us how - important each parameter is to disease transmission. Sensitivity analysis is mainly utilized to describe the robustness of model forecasting to the parameter values (since there are usually errors in the collection of data and presumed model parameter values) [@bib0033]. Here, we perform a sensitivity analysis of the basic reproductive number *R* ~0~ to quantify the fluctuations in the SAIU model parameters. Now from this, we can identify the parameters that have a high impact on the basic reproduction number as well as on the disease transmission. Sensitivity indices permit us to quantify the relative change in a state variable when a parameter alters. The normalized forward sensitivity index of a variable to a parameter is the ratio of the relative change in the variable to the relative change in the parameter. The normalized forward sensitivity index of *R* ~0~ with a parameter *α~u~* is defined as follows:$$\Pi_{\alpha_{u}}^{R_{0}} = {\frac{\partial R_{0}}{\partial\alpha_{u}} \times \frac{\alpha_{u}}{R_{0}}.}$$

Similarly, for other parameter values we can calculate the sensitivity indices of *R* ~0~ for the explicit expression for the basic reproduction number. As for example, the sensitivity indices of *R* ~0~ with respect to *β~s~* is given by$$\Pi_{\beta_{s}}^{R_{0}} = {\frac{\partial R_{0}}{\partial\beta_{s}} \times \frac{\beta_{s}}{R_{0}} = 1.}$$

It can be noted that sensitivity indices may depend on several parameters for the SAIU system, but also can be constant, independent of any parameters. As for example, $\Pi_{\beta_{s}}^{R_{0}} = + 1$ describes that increasing (decreasing) *β~s~* by a given percentage increases (decreases) always *R* ~0~ by that same percentage. We perform the sensitivity analysis for the parameters with effective care, since a small perturbation in such parameter leads to relevant quantitative changes. On the other hand, the estimation of a parameter with a rather small value for the sensitivity indices does not require much attention to estimate, because a small perturbation in that parameter leads to small changes.

From the [Table 2](#tbl0002){ref-type="table"} and the [Fig. 5](#fig0005){ref-type="fig"}, we can observe that the most sensitive parameters to the basic reproduction number *R* ~0~ for the SAIU model system [(1)](#eq0001){ref-type="disp-formula"} are *β~s~, μ* and *α~u~*. More precisely, an increase of the value of *α~u~* will increase the basic reproduction number *R* ~0~ by 77.65% and this happens, in a similar way, for the parameter *α~a~*. In contrast, an increase of the value of *μ* will decrease the basic reproduction number *R* ~0~ by 60.60%.

5. Numerical simulations {#sec0013}
========================

We have calibrated our SAIU model system [(1)](#eq0001){ref-type="disp-formula"} for the novel coronavirus diseases to the daily new infected cases for the Republic of India. The data are collected from daily new infected cases and confirmed cumulative cases for India for the time period January 30, 2020 to April 30, 2020 from the WHO website [@bib0035]. In order to fit the data we use ODE45 in MATLAB and estimate the parameter values that give the best fit for our SAIU model. The proposed SAIU model system [(1)](#eq0001){ref-type="disp-formula"} has 9 nonnegative parameter values among which, we have estimated 6 parameters, namely *β~s~* (probability rate of disease transmission), *α~a~* (adjustment factor for asymptomatic individuals), *α~u~* (adjustment factor for reported symptomatic infected individuals), *γ~a~* (transition rate from asymptomatic to symptomatic infected individuals), *η~i~* (average time reported symptomatic infectious have symptoms) and *η~u~* (average time unreported symptomatic infectious have symptoms) based on the sensitivity analysis [@bib0034]. To minimize the errors we fit the curve for daily confirmed cases and cumulative confirmed cases, which has been shown in the [Fig. 2](#fig0002){ref-type="fig"} and the initial population sizes are given in the figure caption. The parameter values for our SAIU model [(1)](#eq0001){ref-type="disp-formula"} corresponding to the best fit curve for India are listed in the [Table 1](#tbl0001){ref-type="table"}, which can be used further to make predictions and simulations of our model.Fig. 2The figures shows the model fitting of daily reported symptomatic infectious individuals (upper panel) and the reported cumulated symptomatic infectious individuals (lower panel) for the SARS-CoV-2 or COVID-19 pandemic in India. The epidemic turning point of the daily reported symptomatic and cumulated cases data from January 30, 2020 to April 30, 2020 (day 1 = January 30, 2020). The observed data points are shown in the red circle and the solid blue line portrays the model simulations. We use the initial size of the population $S_{0} = 100,$$A_{0} = 10,$$I_{0} = 1,$$U_{0} = 5$ and $t_{0} = 1.0$.Fig. 2

For the set of parameter values listed in the [Table 1](#tbl0001){ref-type="table"}, we draw a surface plot for the basic reproduction number *R* ~0~ with respect to the disease transmission coefficient *β~s~* and the transition rate *γ~a~* from asymptotic individuals to symptomatic individuals. For the basic reproduction number $R_{0} = \frac{\beta_{s}}{\gamma_{a} + \mu}\left( \alpha_{a} + \frac{\alpha_{u}\gamma_{a}\left( 1 - q_{i} \right)}{\eta_{u} + \mu} \right),$ we compute the followings:$$\begin{array}{rcl}
\frac{dR_{0}}{d\beta_{s}} & = & {\frac{1}{\gamma_{a} + \mu}\left( \alpha_{a} + \frac{\alpha_{u}\gamma_{a}\left( 1 - q_{i} \right)}{\eta_{u} + \mu} \right),} \\
\frac{dR_{0}}{d\gamma_{a}} & = & {\frac{\beta_{s}\left( \alpha_{u}\mu\left( 1 - q_{i} \right) - \alpha_{a}\left( \mu + \eta_{u} \right) \right)}{\left( \gamma_{a} + \mu \right)^{2}\left( \eta_{u} + \mu \right)}.} \\
\end{array}$$

From the above expressions, we note that $\frac{dR_{0}}{d\beta_{s}}$ is always positive and $\frac{dR_{0}}{d\gamma_{a}}$ becomes negative if $\frac{\alpha_{u}\left( 1 - q_{i} \right)}{\alpha_{a}}\mspace{6mu} < \mspace{6mu} 1 + \frac{\eta_{u}}{\mu}$. For the listed parameters in the [Table 1](#tbl0001){ref-type="table"}, we have seen that $\frac{dR_{0}}{d\gamma_{a}}$ is negative. As the transmission coefficient *β~s~* increases, *R* ~0~ will increase and cross the threshold $R_{0} = 1,$ thus leading to the outbreak of the coronavirus diseases. In the [Fig. 3](#fig0003){ref-type="fig"} , the red surface indicates the threshold $R_{0} = 1$. Moreover, when the transition rate *γ~a~* of asymptotic individuals to symptomatic individuals increases, *R* ~0~ will decrease and if *R* ~0~ goes below 1, the coronavirus will die out and the population will be free from COVID-19 or SARS-CoV-2. In the [Fig. 3](#fig0003){ref-type="fig"}, the magenta surface indicates the threshold $R_{0} = 2$. Therefore, our model simulation reveals that the transition rate *γ~a~* aid in helping to eradicate the coronavirus diseases by reducing the basic reproduction number *R* ~0~. Also, we can control the reproduction *R* ~0~ by reducing the transmission coefficient *β~s~*. The parameter values obtained from data fit for India as are listed in the [Table 1](#tbl0001){ref-type="table"}, we compute $R_{0} = 1.6632,$ which indicates that the coronavirus diseases spread throughout the India, if we not take preventive measures like social distancing, frequently wash hand by sanitizer etc.Fig. 3The figure shows the basic reproduction number *R*~0~ when *β~s~* (probability of disease transmission rate) and *γ~a~* (rate of transition from asymptomatic to symptomatic infectious class) varies. The other parameter values are listed in the [Table 1](#tbl0001){ref-type="table"}.Fig. 3Table 1Table of biologically relevant parameter values and their interpretation for the SAIU model [(1)](#eq0001){ref-type="disp-formula"} of COVID-19.Table 1SymbolInterpretationValues (Unit)Source$\Lambda_{s} = \mu \times N\left( 0 \right)$net inflow of susceptible individuals−−*β~s~*probability of disease transmission rate0.274 $day^{- 1}$Estimated*α~a~*modification factor for asymptomatic individuals0.4775Estimated*α~u~*modification factor for reported symptomatic class0.695Estimated*μ*natural death rate for all the individuals0.062 $day^{- 1}$[@bib0020]*γ~a~*rate of transition from asymptomatic to symptomatic class0.29 $day^{- 1}$Estimated*q~i~*fraction of asymptomatic infectious become reported symptomatic infectious0.078Assumed$\frac{1}{\eta_{i}}$average time reported symptomatic individuals have symptoms0.009 $day^{- 1}$Estimated$\frac{1}{\eta_{u}}$average time unreported symptomatic individuals have symptoms0.05 $day^{- 1}$Estimated*N*total number of individuals1,352,642,280[@bib0036]Table 2Sensitivity indices of the basic reproduction number *R*~0~ to parameters for the SAIU COVID-19 model, evaluated at the baseline parameter values listed in the [Table 1](#tbl0001){ref-type="table"}.Table 2*Parametersβ~s~*          *μγ~a~α~a~η~u~*    *α~u~q~i~Values*1.000− 0.6060−0.184640.22348−0.346660.77652−0.06474

For the estimated parameter values in the [Table 1](#tbl0001){ref-type="table"}, our model predicts that there will be a high peak for the coronavirus diseases around 60 days and after that the peak will be decreased and the curve become plateau (see the [Fig. 4](#fig0004){ref-type="fig"} for model prediction). But, the novel coronavirus will persists among the people for a long days. It is extremely difficult to predict the end date of the coronavirus diseases. Thus, we always have to maintain social distancing like lockdown, extension of closing schools and colleges, stop cultural events, bar and shopping mall etc. The SAIU model is concise in framework, and it fortunately captures the course of the COVID-19 or SARS-CoV-2 epidemic, and thus sheds light in understanding the trends of the epidemic.Fig. 4The figures shows the prediction of our SAIU model [(1)](#eq0001){ref-type="disp-formula"} for the Republic of India. Here, $\Lambda_{s} = 2500,$$q_{i} = 0.58$ and the initial values are $S_{0} = 4000,$$A_{0} = 3000,$$I_{0} = 10,$$U_{0} = 1000$ rest of the parameter values are listed in the [Table 1](#tbl0001){ref-type="table"}. The model simulation demonstrates that about 60 days the peak will be higher for the COVID-19 in India and after that the curve will be flatten but the coronavirus diseases will be continued for a long-time with lesser magnitude.Fig. 4Fig. 5The figure shows the sensitivity indices of the basic reproduction number *R*~0~ with respect to the each of the system parameters related to *R*~0~ for the SAIU model system [(1)](#eq0001){ref-type="disp-formula"}. The baseline parameter values are taken from the [Table 1](#tbl0001){ref-type="table"}. The simulation exhibits that the most influential parameter is the probability of disease transmission rate (*β~s~*), and the least influential parameter is the fraction of asymptomatic infected individuals become reported symptomatic infected individuals at the rate *q~i~*. The list of sensitivity indices are given in the [Table 2](#tbl0002){ref-type="table"}.Fig. 5

In order to control the COVID-19, we must have to control the threshold level of *R* ~0~. Thus, we plot the sensitivity indices in the [Fig. 5](#fig0005){ref-type="fig"} to understand the most sensitive parameters with respect to *R* ~0~. From the [Fig. 5](#fig0005){ref-type="fig"} and the [Table 2](#tbl0002){ref-type="table"}, we can see that the parameters *β~s~* (disease transmission coefficient), *α~a~* (adjustment factor for asymptomatic individuals), and *α~u~* (adjustment factor for reported symptomatic infected individuals) have positively correlated sensitivity indices and the parameters *μ* (natural mortality rate of entire individuals due to COVID-19 deaths), *γ~a~* (transition rate from asymptomatic individuals to symptomatic individuals), *η~u~* (average time for the unreported individuals have symptoms) and *q~i~* (fraction of asymptomatic infected individuals become reported symptomatic individuals) have negatively correlated sensitivity indices. Therefore, the sensitivity graph is very useful to control the basic reproduction number *R* ~0~.

In addition, we draw the contour plots for the basic reproduction number *R* ~0~ with respect to the parameters *β~s~* versus *α~u~, α~a~, γ~a~* and *q~i~* for the SAIU model [(1)](#eq0001){ref-type="disp-formula"} to study the influence of the control parameters in controlling the reproduction number *R* ~0~. From the [Fig. 6](#fig0006){ref-type="fig"} ((a), (b)), it can be observed that *R* ~0~ increases remarkably for increasing the value of *α~a~, α~u~* and *β~s~*. We can notice from the [Fig. 6](#fig0006){ref-type="fig"} (c), that *R* ~0~ increases for increasing the value of *β~s~* and *γ~a~* but not like [Fig. 6](#fig0006){ref-type="fig"} ((a), (b)). Interestingly, the value of *R* ~0~ can be controlled by increasing the value of *q~i~* (see the [Fig. 6](#fig0006){ref-type="fig"} (d)). Thus, we may conclude that the threshold parameter *R* ~0~ is highly effective with respect to the parameters who have highly negatively correlated sensitivity indices. For all the sub-plots of the [Fig. 6](#fig0006){ref-type="fig"}, it can be noticed that the reproduction number *R* ~0~ is always increased for increasing values for *β~s~*. Thus, to eliminate the coronavirus diseases we must reduce the disease transmission rate and the disease transmission rate can be reduced by controlling *β~s~*. Now, we may conclude that the social distancing is the main non-pharmaceutical measure to end the novel coronavirus.Fig. 6Contour plots for the SAIU model system [(1)](#eq0001){ref-type="disp-formula"}. Contour plots of basic reproduction number *R*~0~ with respect to the most effective parameters, *β~s~* (probability of disease transmission) versus (a) modification factor for the reported symptomatic infected individuals (*α~u~*), (b) modification factor for the asymptomatic infected individuals (*α~a~*), (c) transition rate (*γ~a~*) from asymptomatic individuals to symptomatic infected individuals, and (d) a portion of pre-symptomatic infected individuals become symptomatic infected individuals at the rate *q~i~*. All the parameter values are listed in the [Table 1](#tbl0001){ref-type="table"} except the varied parameters.Fig. 6

6. Discussion {#sec0014}
=============

The reported cases of COVID-19 are rising throughout the world and the human-to-human transmission of coronavirus diseases is already established, thus predicting is the highest priority for the control and management the diseases with limited resource. In our study, we proposed and analyzed the SAIU model to study the transmission dynamics of COVID-19 based on the accessible data [@bib0035] for India during the time period January 30, 2020 to April 30, 2020. Based on the estimated data our SAIU model predict the outbreak of COVID-19 or SARS-CoV-2 virus. We compute the basic reproduction number *R* ~0~, which can be used further for model simulation and predictions.

We studied the SAIU model for COVID-19 assessing the sensitivity indices of the basic reproductive number *R* ~0~, as *R* ~0~ quantifies the initial disease transmission and the sensitivity indices allow us to describe the relative importance of various parameters in coronavirus transmission. We perform the local and global asymptotic stability analysis for the infection free equilibrium point *E* ~0~ in case of *R* ~0~ \< 1. Furthermore, the SAIU model showed the persistence of diseases for *R* ~0~ \> 1. The endemic equilibrium point *E*\* is locally asymptotically stable for *R* ~0~ \> 1. Constructing suitable Lyapunov function followed by Korobeinikov & Maini [@bib0027], we showed that the our SAIU model is globally asymptotically stable for *R* ~0~ \> 1. Theoretically, we showed that at $R_{0} = 1,$ our SAIU model undergoes transcritical bifurcation.

We calibrated our proposed SAIU model to fit with daily and cumulative confirmed cases of India. For the estimated parameter values, we obtained $R_{0} = 1.6632,$ which shows the substantial outbreak of novel coronavirus in India. The reproduction number *R* ~0~ can be controlled by reducing the disease transmission rate *β~s~* and by increasing the quantity *q~i~* also by increasing the adjustment factors *α~a~* and *α~u~*, which has been shown by contour plot in the [Fig. 6](#fig0006){ref-type="fig"}. This indicates that the elimination of COVID-19 is possible by maintaining the social distances like contact tracing, lockdown and use precautionary measures. Also, the policymakers as well as the health care agencies should concentrate on successful implementation of control mechanisms to minimize the burden of the coronavirus diseases. Our model simulations nicely capture the increasing trend of the course of the COVID-19 epidemic (see the [Fig. 2](#fig0002){ref-type="fig"}). Sensitivity indices reveal that the disease transmission rate *β~s~* is positively correlated and the proportion rate *q~i~* of asymptomatic infected population reported symptomatic infected individuals negatively correlated with respect to the reproduction number *R* ~0~. This implies that increasing *q~i~* and decreasing the disease transmission rate *β~s~* will decrease the reproduction number *R* ~0~ and consequently will reduce the disease burden. While investigating the contour plots (see [Fig. 6](#fig0006){ref-type="fig"}), it can be seen that effective management of disease transmission rate *β~s~* is more influential to mitigate the reproduction number *R* ~0~ below 1.

Based on the estimated data, our SAIU model predict that there will be a highest peak around 60 days if human-to-human transmission and the personal preventive measures continue with the existing rates. Around 60 days later the peak will be decreased but the CODIV-19 disease will persist for a long time. In absence of any pharmaceutical measures, the public must have to obey the government rules or public health care policies to mitigate the spread of novel coronavirus. It is really difficult to predict the outbreak of COVID-19 in India and throughout the world. In order to get more accurate prediction, we need to get more accurate data. It is worthy to mention that the researchers are working for therapeutics or vaccine to eliminate novel coronavirus and the presence of such pharmaceutical interventions will remarkably change the outcomes.
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